Remove Government Remove Leads Remove Patients Remove Pharmaceutical manufacturing
article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.

article thumbnail

A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

PM360

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. The price is available to cash-paying patients with a valid prescription. for only $35. Currently, an estimated 37.3

Retail 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. Some suggest that the government should incentivize U.S. Over 300 drugs in the U.S.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.

article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. The sheer pressure on the pharmaceutical industry to innovate caused a surge of job roles in IT, research and development (R&D), sales, and marketing.